1. Corporate Officers - W
2. Witte Owen N.

Insider Trading History of Witte Owen N.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Witte Owen N. since 2017. This trader's CIK number is 1700969. At the time of last reporting, Witte Owen N. was the Director of Allogene Therapeutics, Inc.. (stock ticker symbol ALLO). Also see all insider trading activities at Allogene Therapeutics, Inc..

Note that in the past WITTE OWEN N. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Allogene Therapeutics, Inc. (ALLO) by Witte Owen N.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2022	ALLO	0	$0	40,000	$620,100	0	$0
2021	ALLO	0	$0	24,969	$612,123	0	$0
2018	ALLO	15,000	$270,000	0	$0	0	$0

Yearly summary of insider trading at Kite Pharma, Inc. (KITE) by Witte Owen N.

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	KITE	0	$0	25,000	$2,507,500	12,500	$433,312

Insider trading activities at 2 companies by Witte Owen N.:

1. Allogene Therapeutics, Inc. (ALLO)

2. Kite Pharma, Inc. (KITE)

Table 1. Insider trading of Allogene Therapeutics, Inc. (ALLO) by Witte Owen N.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2022-08-11	ALLO	Sale	10,000	16.50	165,000
2022-08-12	ALLO	Sale	5,000	17.25	86,250
2022-08-11	ALLO	Sale	10,000	16.50	165,000
2022-08-12	ALLO	Sale	5,000	17.25	86,250
2022-06-22	ALLO	Sale	10,000	11.76	117,600
2021-09-09	ALLO	Sale	5,000	25.54	127,700
2021-08-20	ALLO	Sale	10,000	23.47	234,700
2021-06-09	ALLO	Sale	9,969	25.05	249,723
2018-10-15	ALLO	Buy	15,000	18.00	270,000

Table 2. Insider trading of Kite Pharma, Inc. (KITE) by Witte Owen N.

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-06-23	KITE	Option Ex	12,500	34.66	433,312
2017-06-23	KITE	Sale	12,500	100.00	1,250,000
2017-06-26	KITE	Sale	12,500	100.60	1,257,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Witte Owen N. (Director of Allogene Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month